To be confirmed

Add to your list(s) Download to your calendar using vCal

• Daniel Crowther
• Wednesday 15 February 2006, 14:00-15:00
• MR5, DAMTP.

If you have a question about this talk, please contact Stephen Eglen.

GlaxoSmithKline is one of the worlds leading pharmaceutical companies. In this talk I will aim to introduce the drug development process and highlight some of the ways in which bioinformatics is applied to the drug development process in GSK . The talk will focus on several key areas of impact, starting with target identification and validation including the application of structural analysis to protein engineering, describe the role of bioinformatics in handing human variation and finishing with at role bioinformatics plays in the discovery and application of biomarkers.

This talk is part of the Computational and Systems Biology series.

This talk is included in these lists:

• All CMS Events
• All Talks (aka the CURE list)
• Biology
• CamBridgeSens
• Cambridge talks
• Computational and Systems Biology
• Graduate-Seminars
• Life Science Interface Seminars
• Life Sciences
• Life Sciences
• ME Seminar
• MR5, DAMTP
• PMRFPS's
• School of Physical Sciences
• Trust & Technology Initiative - interesting events
• custom
• my_list
• other talks
• se393's list

Note that ex-directory lists are not shown.